MSH2 and cancer: Additionally, these patients may be suffering from sporadic cancer as a result of somatic mosaicism of the APC pathogenic variant [24], somatic hypermethylation of the MLH1 gene [25], germline hypermethylation of MSH2 (via 3' end deletions in the EPCAM gene) [26], or confluence of genetic and environmental risk factors.